Atlas Trials

Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease

Clinical trial NCT05677633 · COMPLETED

Trial details

NCT number
NCT05677633
Sponsor
University of Nebraska
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease and Parkinsonism
Start date
2023-01-19
Primary completion
2024-04-12
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.